Startup Logo

reflectUS

Hand-held ultrasound device for breast cancer diagnosis


  • 4-7 Team Size
  • 2016 Founding Year
  • Zurich, Switzerland Location
  • Idea, pre-funding Project Status
  • www.youtube.com/watch?v=_cfzUU1oayQ Website
  • medical devices, medtech, imaging technology Markets

The faster breast cancer is diagnosed, the higher is the chance for a cure. X-ray mammography is the current choice for breast screening, however, it requires radiation exposure and causes discomfort. Ultrasound is safe, however, conventional images based on tissue scattering are not sensitive to cancer. On the other hand, tumors are stiffer than the surrounding tissue, and, as a result, sound travels faster through them. Consequently, if we can measure the local speed-of-sound we can infer if a point is a cancer or a normal tissue. We have developed a hand-held apparatus that uses a conventional ultrasound probe on one side of the tissue and a passive reflector on the other side. With this setup, we measure the travel time along multiple wave paths, and devise mathematical techniques to reconstruct SoS images, which successfully delineate stiff tissue locations. This low-cost technology can bring hand-held breast screening to individual doctors’ offices. In the fight against breast cancer, speed is now not only a must, but also a convenience medical diagnosis tool.

News

07.11.2017

Three Medtech start-ups awarded at >>venture>>

Lumigbo and reflectUS were awarded the prize for the best business plan and the best business idea respectively. The first audience award went to Twiice. Next year the award ceremony will be held for the first time at EPFL.

20.06.2017

Three Medtech start-ups awarded at >>venture>>

Lumigbo and reflectUS were awarded the prize for the best business plan and the best business idea respectively. The first audience award went to Twiice. Next year the award ceremony will be held for the first time at EPFL.

Team

Sergio Sanabria

Founder